MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0005692
Mahak Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹7.89 Cr
▲ 322% YoY
Net profit · FY 2024
₹41.78 Lakh
Net margin 5.3%
EBITDA · FY 2024
₹46.31 Lakh
EBITDA margin 5.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Mahak Pharma Private Limited
Data last updated:
Mahak Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC279215. Its GSTIN is 07AAJCM7326F1ZE (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rishab Jain and Madhu Jain.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 11/2 A Pusa Road, New Delhi, Delhi, India – 110005.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.89 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹41.78 Lakh (net margin 5.3%) and EBITDA of ₹46.31 Lakh (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 68% over three years and 123% over five years.
As per MCA filings, the company has open charges of ₹1 Cr on record.
Mahak Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0005692). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dromenco.com.
Company details
CIN U24100DL2015PTC279215
Registration Number 279215
Incorporation Date 18 April 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0005692
Recognitions & Rankings of Mahak Pharma
Contact details
Mahak Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered Address11/2 A Pusa Road, New Delhi, Delhi, India – 110005
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mahak Pharma Private Limited, buy the company report.
Comprehensive company report
Mahak Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Mahak Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mahak Pharma Private Limited, buy the company report.
Financials of Mahak Pharma Private Limited
FY 2024 filings availableMahak Pharma Private Limited reported revenue of ₹7.89 Cr (up 322% YoY) for FY 2024.
Revenue · FY 2024
₹7.89 Cr ▲ 322%
Net profit · FY 2024
₹41.78 Lakh margin 5.3%
EBITDA · FY 2024
₹46.31 Lakh margin 5.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 322%
3 years · compounded
▲ 68%
5 years · compounded
▲ 123%
EBITDA CAGR growth
1 year
▲ 134%
3 years · compounded
▲ 24%
5 years · compounded
▲ 261%
Revenue has grown at a compounded annual rate (CAGR) of 123% over five years, including 322% growth in the latest year. EBITDA rose 134% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹46.31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41.78 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mahak Pharma Private Limited, buy the company report.
Board of directors of Mahak Pharma Private Limited
Mahak Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishab Jain | Director | 16 Aug 2022 | 4 Years 2 Months | Current |
| Madhu Jain | Additional Director | 25 Aug 2025 | 1 Years 1 Months | Current |
Peer comparison
Mahak Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Spasibo Enterprise Private Limited | ₹7.9 Cr (FY 2025) | -47.0% | Bishnupur, West Bengal, India | |||
| Raj Capsules Private Limited | ₹7.9 Cr (FY 2025) | 20.0% | Delhi, India | |||
| Nephcore India Private Limited | ₹7.89 Cr (FY 2024) | 38.0% | Delhi, India | |||
| Eva Biotech Private Limited | ₹7.89 Cr (FY 2024) | 111.0% | Jaipur, Rajasthan, India | |||
| Mahak Pharma Private Limitedthis company | ₹7.89 Cr (FY 2024) | ₹41.78 Lakh | 5.3% | 322.0% | New Delhi, Delhi, India |
To see the full peer comparison of Mahak Pharma Private Limited, buy the company report.
Auditor
Mahak Pharma Private Limited is audited by SINGH MEHRA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGH MEHRA & ASSOCIATES | FY 2023 | 034086N |
Shareholding
The shareholding of Mahak Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mahak Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jan 2024 | 100872194 | Others | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Mahak Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mahak Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mahak Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCM7326F1ZE | Delhi | Active | 13 Oct 2017 |
| 06AAJCM7326F1ZG | Haryana | Active | 19 Mar 2020 |
To see the full GST registrations and return filing status of Mahak Pharma Private Limited, buy the company report.
Recent activity
Mahak Pharma Private Limited has 7 board changes on record since 2017: 3 appointments and 4 cessations. The latest: Madhu Jain was appointed as Additional Director on 25 Aug 2025.
Appointed
Madhu Jain was appointed as Additional Director.
AGM
Mahak Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
Filing
Mahak Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 100872194 was registered on 31 Jan 2024.
Ceased
Rishab Jain ceased to be Additional Director.
Ceased
Madhu Jain ceased to be Director.
Ceased
Raj Kumar Jain ceased to be Director.
Appointed
Rishab Jain was appointed as Director.
Ceased
Kanishka Jain ceased to be Additional Director.
Appointed
Kanishka Jain was appointed as Director.
Incorporation
18 Apr 2015
Mahak Pharma Private Limited was registered on 18 Apr 2015 with Roc Delhi & aged 11 years 6 months as per MCA records.
Frequently asked questions
Mahak Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 April 2015 (11+ years old) and is registered under CIN U24100DL2015PTC279215.
Mahak Pharma has 2 current directors:
- Rishab Jain - Director
- Madhu Jain - Additional Director
The latest financial statements of Mahak Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Mahak Pharma is 07AAJCM7326F1ZE, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAJCM7326F1ZG (Haryana).
The CIN (Corporate Identification Number) of Mahak Pharma is U24100DL2015PTC279215. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mahak Pharma was incorporated on 18 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Mahak Pharma by revenue are Spasibo Enterprise Private Limited, Raj Capsules Private Limited, Nephcore India Private Limited, Eva Biotech Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Madhu Jain was appointed as Additional Director on 25 Aug 2025. Rishab Jain ceased to be Additional Director on 30 Sep 2022. Madhu Jain ceased to be Director on 17 Aug 2022. Mahak Pharma has 7 board changes on record in total.
Yes, Mahak Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0005692).
Mahak Pharma can be reached through the website dromenco.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Mahak Pharma is at 112 A Pusa Road, New Delhi, Delhi, India – 110005.